Legal & General Group’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $748K | Buy |
78,533
+10,060
| +15% | +$95.8K | ﹤0.01% | 2321 |
|
|
2025
Q1 | $716K | Buy |
68,473
+8
| +0% | +$84 | ﹤0.01% | 2295 |
|
|
2024
Q4 | $1.61M | Sell |
68,465
-37,982
| -36% | -$895K | ﹤0.01% | 2069 |
|
|
2024
Q3 | $3.82M | Buy |
106,447
+46,113
| +76% | +$1.66M | ﹤0.01% | 1698 |
|
|
2024
Q2 | $2.13M | Buy |
60,334
+16,233
| +37% | +$573K | ﹤0.01% | 1922 |
|
|
2024
Q1 | $1.25M | Buy |
44,101
+19,827
| +82% | +$563K | ﹤0.01% | 2118 |
|
|
2023
Q4 | $323K | Buy |
24,274
+182
| +0.8% | +$2.42K | ﹤0.01% | 2605 |
|
|
2023
Q3 | $216K | Sell |
24,092
-408
| -2% | -$3.66K | ﹤0.01% | 2706 |
|
|
2023
Q2 | $276K | Buy |
24,500
+13,796
| +129% | +$155K | ﹤0.01% | 2663 |
|
|
2023
Q1 | $123K | Buy |
10,704
+282
| +3% | +$3.25K | ﹤0.01% | 2736 |
|
|
2022
Q4 | $121K | Hold |
10,422
| – | – | ﹤0.01% | 2776 |
|
|
2022
Q3 | $133K | Sell |
10,422
-2,335
| -18% | -$29.8K | ﹤0.01% | 2742 |
|
|
2022
Q2 | $88K | Buy |
12,757
+4,779
| +60% | +$33K | ﹤0.01% | 2887 |
|
|
2022
Q1 | $77K | Hold |
7,978
| – | – | ﹤0.01% | 2925 |
|
|
2021
Q4 | $95K | Hold |
7,978
| – | – | ﹤0.01% | 2920 |
|
|
2021
Q3 | $129K | Buy |
7,978
+4,577
| +135% | +$74K | ﹤0.01% | 2797 |
|
|
2021
Q2 | $71K | Buy |
3,401
+1,685
| +98% | +$35.2K | ﹤0.01% | 2840 |
|
|
2021
Q1 | $27K | Buy |
1,716
+239
| +16% | +$3.76K | ﹤0.01% | 3022 |
|
|
2020
Q4 | $31K | Buy |
1,477
+982
| +198% | +$20.6K | ﹤0.01% | 2940 |
|
|
2020
Q3 | $10K | Buy |
+495
| New | +$10K | ﹤0.01% | 3223 |
|